Hercules Capital Inc (HTGC) - News Archive

MoonLake Immunotherapeutics, a clinical-stage biotechnology firm headquartered in Zug, Switzerland, has made significant strides in its financing strategy by securing up to $500 million in non-dilutive capital from Herc...

In an era marked by rapid technological advancement and relentless innovation, Hercules Capital, Inc. (NYSE: HTGC) has made a bold move to double down on its commitment to supporting growth and innovation. The San Mateo...

Hercules Capital, a leading specialty financing provider, has recently received approval from the U.S. Small Business Administration (SBA) for its fourth Small Business Investment Company (SBIC) subsidiary. This new dev...

SAN MATEO, Calif. - Hercules Capital, a leading provider of growth capital to innovative entrepreneurs, is celebrating a significant milestone as it reaches $20.0 billion in cumulative debt commitments. This achievement...

for :Hercules Capital Receives Upgraded BBB Investment Grade Rating with Positive Outlook from Morningstar DBRSSAN MATEO, Calif. - Hercules Capital, Inc. (NYSE: HTGC), the foremost provider of specialty financing to inn...